Volume 40 Issue 3
Mar.  2024
Turn off MathJax
Article Contents
WANG Yan, GAO Tiantian, WANG Ziying, CHEN Gang, TAO Weiwei. Effects of Yueju Pill on Depressive Behavior, Functional Dyspepsia and PACAP/PAC1-R Expression in CUMS Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(3): 261-267. doi: 10.14148/j.issn.1672-0482.2024.0261
Citation: WANG Yan, GAO Tiantian, WANG Ziying, CHEN Gang, TAO Weiwei. Effects of Yueju Pill on Depressive Behavior, Functional Dyspepsia and PACAP/PAC1-R Expression in CUMS Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(3): 261-267. doi: 10.14148/j.issn.1672-0482.2024.0261

Effects of Yueju Pill on Depressive Behavior, Functional Dyspepsia and PACAP/PAC1-R Expression in CUMS Mice

doi: 10.14148/j.issn.1672-0482.2024.0261
  • Received Date: 2023-11-09
    Available Online: 2024-03-15
  •   OBJECTIVE  To explore the effects of Yueju Pill on depression and gastrointestinal function in depressed co-morbid functional dyspepsia mice.  METHODS  C57BL/6J mice were randomly divided into control group, model group, Yueju Pill low-dose group, Yueju Pill high-dose group and positive drug group. A co-morbidity model was constructed using chronic unpredictable mild stress (CUMS), and the mice were assessed for depression-like behaviour and neuronal damage by behavioural tests and Nissl staining; gastrointestinal function was assessed by HE staining of gastric and intestinal tissues, gastric emptying rate, and small intestinal propulsive rate; PACAP, VIP, IL-6, TNF-α, and BDNF expression were detected by ELISA; PAC1-R, Vipr1, and Vipr2 protein expression were detected by protein immunoblotting.  RESULTS  Mice in the model group showed depression-like behaviour, reduced number of hippocampal nidus, slowed gastrointestinal motility, elevated serum inflammatory factors IL-6 and TNF-α (P < 0.05, P < 0.01), and reduced expression of PACAP, VIP, and BDNF (P < 0.05, P < 0.01), The PAC1-R, VPAC1-R, VPAC2-R expression decreased in the hippocampus and gastric sinus, duodenal tissue (P < 0.05, P < 0.01). Compared with the model group, the low and high dose groups of Yueju Pill improved the above indexes except for Vipr1 and Vipr2 (P < 0.05, P < 0.01).  CONCLUSION  Yueju Pill can reduce inflammatory factors through PACAP/PAC1-R, increase the level of BDNF, and improve the depression-like behaviour and gastrointestinal dysfunction in CUMS mice.

     

  • loading
  • [1]
    HUANG J, CAI Y Y, SU Y S, et al. Gastrointestinal symptoms during depressive episodes in 3256 patients with major depressive disorders: Findings from the NSSD[J]. J Affect Disord, 2021, 286: 27-32. doi: 10.1016/j.jad.2021.02.039
    [2]
    KOP W J. Somatic depressive symptoms, vital exhaustion, and fatigue: Divergent validity of overlapping constructs[J]. Psychosom Med, 2012, 74(5): 442-445. doi: 10.1097/PSY.0b013e31825f30c7
    [3]
    张煜萱, 崔博, 邹之璐, 等. 越鞠丸治疗气郁体质抑郁症患者及改善血清BDNF水平的临床对照研究[J]. 辽宁中医杂志, 2018, 45(5): 960-963. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201805021.htm

    ZHANG Y X, CUI B, ZOU Z L, et al. Clinical observation on effect of Yueju pill in treating qi-stagnation constitution depression patients[J]. Liaoning J Tradit Chin Med, 2018, 45(5): 960-963. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201805021.htm
    [4]
    李劲亮. 越鞠丸辅治肝胃不和型功能性消化不良的临床效果观察[J]. 临床合理用药杂志, 2018, 11(23): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201823022.htm

    LI J L. Clinical observation of Yueju Pill in adjuvant treatment of functional dyspepsia with disharmony between liver and stomach[J]. Chin J Clin Ration Drug Use, 2018, 11(23): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201823022.htm
    [5]
    REN L, ZHANG H L, TAO W W, et al. Hippocampal pituitary adenylate cyclase-activating polypeptide mediates rapid antidepressant-like effects of Yueju pill[J]. Neuropeptides, 2023, 101: 102350. doi: 10.1016/j.npep.2023.102350
    [6]
    杜鹃, 柯道平, 孔德虎. 垂体腺苷酸环化酶激活肽对胃肠道分泌与运动的影响[J]. 四川生理科学杂志, 2003(1): 1-4. doi: 10.3969/j.issn.1671-3885.2003.01.001

    DU J, KE D P, KONG D H. Effects of pituitary adenylate cyclase activating peptide on gastrointestinal secretion and motility[J]. Sichuan J Physiol Sci, 2003(1): 1-4. doi: 10.3969/j.issn.1671-3885.2003.01.001
    [7]
    郑劼, 许一凡, 陈艳燕, 等. 甘麦大枣汤联合氟西汀通过调控肠道菌群改善慢性应激小鼠抑郁症状的研究[J]. 南京中医药大学学报, 2020, 36(5): 667-674. http://xb.njucm.edu.cn/article/id/zr20200515

    ZHENG J, XU Y F, CHEN Y Y, et al. Ganmai Dazao Decoction combined with fluoxetine treatment alleviates depressive symptoms in chronic stress mice by modulating intestinal microbiota[J]. J Nanjing Univ Tradit Chin Med, 2020, 36(5): 667-674. http://xb.njucm.edu.cn/article/id/zr20200515
    [8]
    陶伟伟, 白子君, 岳启予, 等. 栀子豉汤对慢性应激诱导的抑郁模型小鼠脑组织神经炎症和突触可塑性的影响[J]. 中医杂志, 2022, 63(11): 1073-1079.

    TAO W W, BAI Z J, YUE Q Y, et al. Effect of zhizichi decoction on neuroinflammation and synaptic plasticity in brain tissue of chronic stress-induced depression model mice[J]. J Tradit Chin Med, 2022, 63(11): 1073-1079.
    [9]
    WANG T, YAN Y F, YANG L, et al. Effects of Zuojin pill on depressive behavior and gastrointestinal function in rats with chronic unpredictable mild stress: Role of the brain-gut axis[J]. J Ethnopharmacol, 2020, 254: 112713. doi: 10.1016/j.jep.2020.112713
    [10]
    赵静怡, 郑金粟, 曹锐. 肝郁脾虚型功能性消化不良中医病证结合模型的研究进展[J]. 北京中医药, 2023, 42(10): 1156-1160. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO202310032.htm

    ZHAO J Y, ZHENG J S, CAO R. Research progress of functional dyspepsia disease and syndrome combination model with liver depression and spleen deficiency[J]. Beijing J Tradit Chin Med, 2023, 42(10): 1156-1160. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO202310032.htm
    [11]
    吴仁军. 越鞠丸加减治疗功能性消化不良142例[J]. 光明中医, 2014, 29(3): 519-520. doi: 10.3969/j.issn.1003-8914.2014.03.041

    WU R J. 142 cases of functional dyspepsia treated by Yueju pill[J]. Guangming J Chin Med, 2014, 29(3): 519-520. doi: 10.3969/j.issn.1003-8914.2014.03.041
    [12]
    WU R Y, ZHU D D, XIA Y C, et al. A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: A randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study[J]. Neuropsychiatr Dis Treat, 2015, 11: 2013-2021.
    [13]
    VAUDRY D, FALLUEL-MOREL A, BOURGAULT S, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery[J]. Pharmacol Rev, 2009, 61(3): 283-357. doi: 10.1124/pr.109.001370
    [14]
    李喜龙, 赵兴绪. 垂体腺苷酸环化酶激活肽的研究概况[J]. 生物化学与生物物理进展, 2001, 28(2): 140-144. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSW200102002.htm

    LI X L, ZHAO X X. Pituitary adenylate cyclase-activating polypeptide[J]. Prog Biochem Biophys, 2001, 28(2): 140-144. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSW200102002.htm
    [15]
    SOLES-TARRES I, CABEZAS-LLOBET N, VAUDRY D, et al. Protective effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide against cognitive decline in neurodegenerative diseases[J]. Front Cell Neurosci, 2020, 14: 221.
    [16]
    REGLODI D, ILLES A, OPPER B, et al. Presence and effects of pituitary adenylate cyclase activating polypeptide under physiological and pathological conditions in the stomach[J]. Front Endocrinol, 2018, 9: 90. doi: 10.3389/fendo.2018.00090
    [17]
    岳双明, 周安国, 王之盛, 等. 垂体腺苷酸环化酶激活多肽(PACAP)的研究概况[J]. 饲料工业, 2007, 28(11): 12-16. https://www.cnki.com.cn/Article/CJFDTOTAL-FEED200711004.htm

    YUE S M, ZHOU A G, WANG Z S, et al. Research advance of pituitary adenylate cyclase activating polypeptide[J]. Feed Ind, 2007, 28(11): 12-16. https://www.cnki.com.cn/Article/CJFDTOTAL-FEED200711004.htm
    [18]
    BATHINA S, DAS U N. Brain-derived neurotrophic factor and its clinical implications[J]. Arch Med Sci, 2015, 11(6): 1164-1178.
    [19]
    LIU S M. Neurotrophic factors in enteric physiology and pathophysiology[J]. Neurogastroenterol Motil, 2018, 30(10): e13446. doi: 10.1111/nmo.13446
    [20]
    LI C, CAI Y Y, YAN Z X. Brain-derived neurotrophic factor preserves intestinal mucosal barrier function and alters gut microbiota in mice[J]. Kaohsiung J Med Sci, 2018, 34(3): 134-141. doi: 10.1016/j.kjms.2017.11.002
    [21]
    AL-QUDAH M, ALKAHTANI R, AKBARALI H I, et al. Stimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptide[J]. Neurogastroenterol Motil, 2015, 27(8): 1162-1174.
    [22]
    ZINK M, OTTO C, ZORNER B, et al. Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor[J]. Neurosci Lett, 2004, 360(1/2): 106-108.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)

    Article Metrics

    Article views (98) PDF downloads(12) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return